Pyrrole-2-Carboxylic Acid, 3,5-Dimethyl-,Ethyl Ester

In the preparative-scale synthesis of 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (BODIPY) fluorophores, 3,5-dimethylpyrrole-2-carboxylic acid ethyl ester functions as the critical precursor to the dipyrromethene framework. The condensation is conducted in anhydrous dichloromethane under an argon counterflow using Schlenk technique, with 2.05 mol of the pyrrole ester charged per 1.0 mol of the aryl aldehyde partner to suppress over-condensation and minimize oligomer byproducts. Trifluoroacetic acid (0.15 mol) catalyzes the formation of the dipyrromethane intermediate, which is subsequently oxidized by 2.3 equivalents of 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) at −20 °C to avoid decomposition. The deep-colored meso-substituted dipyrromethene is then treated with boron trifluoride etherate (2.5 equiv) in the presence of triethylamine (3.0 equiv) in toluene at room temperature to form the BODIPY core. Entire synthesis must remain strictly anhydrous; residual moisture above 50 ppm in the solvent consistently reduces complexation yield by 15–20% due to BF₂ hydrolysis. Industry compliance for such fluorescent reporters, when employed as components of in-vitro diagnostic kits, requires adherence to ISO 13485:2016 and, for immunohistochemical use, purity specifications benchmarked against Ph. Eur. 2.2.29 (HPLC assay). The ethyl ester starting material routinely meets a purity threshold of >98.5% by GC-FID prior to use. In the final formulation, the BODIPY dye is conjugated to monoclonal antibodies (e.g., anti-CD4, anti-HER2) via NHS-ester coupling under pH 8.5 borate buffer; the conjugate solution is then buffer-exchanged through a Sephadex G-25 column to eliminate free dye. End-use formats include flow cytometry vials containing 0.1 mg/mL tagged antibody in PBS with 0.1% sodium azide, fluorescence in-situ hybridization (FISH) probe kits for chromosome enumeration, and boron-dipyrromethene-derivatized oligonucleotides for quantitative real-time PCR detection. Production-scale freeze-drying in amber vials at −50 °C and 0.02 mbar shelf pressure preserves quantum yields above 0.85 for 18 months at 2–8 °C as verified by absolute PLQY measurement per ISO 20473:2007.

To What Extent Does the Partially Hydrolyzed Ethyl Ester Passivate Mild Steel in High-Water-Dilution Metalworking Fluids?

In semi-synthetic coolant formulations where 3,5-dimethylpyrrole-2-carboxylic acid ethyl ester is deliberately pre-hydrolyzed during the emulsification step (pH 9.0, 55 °C, 90 min), the resulting carboxylate anion exerts anodic passivation on low-carbon steel surfaces. A stock concentrate containing 0.8–1.2 wt% of the ester is mixed with naphthenic base oil, petroleum sulfonate emulsifiers, and a triazine biocide; after dilution to 5% v/v in tap water (hardness 150 ppm as CaCO₃), the working fluid delivers 40–60 ppm of the active corrosion inhibitor. Performance validation is conducted on pre-ground SAE 1010 steel panels in accordance with ASTM D665-19 Procedure B (synthetic seawater immersion). Formulations employing the pyrrole ester without supplemental carboxylic acid boosters consistently achieve zero rust at 12 hours, and with optimized co-inhibitors, the protection endures 24 hours; failure typically initiates at the waterline in the absence of sufficient reserve alkalinity. Electrochemical impedance spectroscopy collected in a three-electrode flat cell under ASTM G106-15 conditions reveals a charge transfer resistance (Rct) increase from 1.2×10³ Ω·cm² (uninhibited) to 8.5×10⁴ Ω·cm² at the 2000 μA/cm² polarization limit when the hydrolyzed ester is present. The downstream blending process requires a high-shear rotor-stator mixer (3000 rpm, 20 min) to ensure uniform droplet size distribution (D₅₀ < 2 µm) because the ester’s limited water solubility (calculated to be <0.5 g/L) can otherwise cause localized inhibitor starvation. Compliance with biocidal product regulations under EU BPR 528/2012 imposes upper concentration limits for the concentrate when the triazine component is included; the pyrrole ester itself is registered under REACH for this use as a non-dangerous substance. Final products are packaged as 205 L drummed semi-synthetic coolant concentrates or pre-diluted 1000 L IBC totes for central coolant systems in CNC machining centers that produce automotive powertrain components.

If the Ethyl Ester is De-Protected to the Free Acid, It Generates a Scaffold Amenable to Parallel Amide Coupling for Kinase Inhibitor Hit-to-Lead Optimization

In early-phase medicinal chemistry programs targeting type II kinase binding sites, 3,5-dimethylpyrrole-2-carboxylic acid (obtained by saponification with 2.0 M LiOH in THF/water, 98% yield) serves as a rigid aromatic spacer whose methyl substituents at positions 3 and 5 restrict conformation and enhance metabolic stability relative to unsubstituted pyrrole analogs. Library synthesis is executed on aminomethyl polystyrene resin (0.8 mmol/g loading) under microwave-assisted coupling conditions at 75 °C using 2.5 equiv of the acid, 2.5 equiv of HATU, and 5.0 equiv of N,N-diisopropylethylamine (DIPEA) in dimethylformamide. The immobilized amide intermediates are cleaved with 95% trifluoroacetic acid containing triisopropylsilane (2.5% v/v) as scavenger to afford discrete compounds for screening. Medicinal chemistry purity is measured against an ICH Q3A-aligned threshold of <0.10% any individual unknown impurity; whether the intermediate falls under the definition of a regulatory starting material is determined by ICH Q11 (Section 5.2.1) and the applicant’s synthetic justification. Contract manufacturing organizations (CMOs) supply the ethyl ester with a certificate of analysis including residual solvent profiling by headspace GC as per USP <467>, ensuring residual ethyl acetate and ethanol below 5000 ppm and 2000 ppm, respectively. Downstream, the amide-based leads are processed through parallel semi-preparative HPLC on a C18 5 µm 150×21.2 mm column to achieve >95% purity prior to IC₅₀ determination in an ADP-Glo™ kinase assay. Terminal products are not a commercial drug but a focused screening library of 96 to 384 compounds, each provided as 1.2 µmol sealed ampules in DMSO stock solution, integrated into a pharmaceutical collaboration agreement.

C2-Symmetric Bis(oxazoline) Ligand Precursor for Copper-Catalyzed Enantioselective Cyclopropanation

The chiral bis(oxazoline) ligand derived from 3,5-dimethylpyrrole-2-carboxylic acid ethyl ester proceeds through a sequence where the ester is first reduced with lithium aluminum hydride (2.2 equiv, 0 °C to reflux) to the corresponding primary alcohol, then oxidized to the aldehyde via Swern conditions (oxalyl chloride, DMSO, triethylamine, −78 °C). Condensation with (S)-tert-leucinol in toluene under Dean–Stark water removal, followed by methanesulfonyl chloride-mediated cyclization, yields the pyrrole-tethered bis(oxazoline). When the ligand is complexed with copper(I) triflate (1 mol% Cu) and employed in the asymmetric cyclopropanation of styrene with ethyl diazoacetate, the catalytic system delivers trans/cis ratios of up to 92:8 and enantiomeric excesses of 98% for the trans isomer as determined by chiral GC per Ph. Eur. 2.2.28. The ligand itself is produced under ISO 9001:2015 quality management by fine chemical suppliers, with batch homogeneity verified by polarimetry (specific rotation +145° ±2° at c 1.0, CHCl₃) and the heavy metal content controlled below 10 ppm to meet ICH Q3D threshold limits for drug precursor applications. The downstream process for the end user involves in situ generation of the active copper carbenoid at 0 °C with slow addition of the diazo compound over 8 hours using a syringe pump, after which the ligand–metal complex is recovered by aqueous extraction. The final commercial product is supplied as a degassed 0.5 M toluene solution in 100 mL Sure-Seal™ bottles, intended for kilogram-scale manufacturing of chiral cyclopropane intermediates that appear in known antiviral and anti-asthmatic API syntheses.

In n-i-p perovskite solar cells utilizing 2,2′,7,7′-tetrakis(N,N-di-p-methoxyphenylamine)-9,9′-spirobifluorene (Spiro-OMeTAD) as the hole-transport material, the p-type doping efficiency is critically enhanced by the addition of 0.3–0.7 mol% of 3,5-dimethylpyrrole-2-carboxylic acid ethyl ester, which is oxidized in situ by the lithium bis(trifluoromethanesulfonyl)imide (Li-TFSI) atmospheric doping scheme to generate polaronic charge carriers. The ester is dissolved in chlorobenzene along with Spiro-OMeTAD (72.3 mg/mL), 4-tert-butylpyridine (28.8 µL/mL), and Li-TFSI (520 mg/mL acetonitrile stock added at 17.5 µL/mL). Spin-coating at 2000 rpm for 30 s in a nitrogen-filled glovebox (<0.1 ppm O₂, <0.5 ppm H₂O) yields a 200 nm film that is subsequently oxidized in dry air (25% RH) for 12 h prior to gold electrode evaporation. Device performance is recorded under AM1.5G illumination (100 mW/cm²) following IEC 60904-1 standard test conditions; champion modules incorporating the pyrrole dopant exhibit stabilized power conversion efficiencies exceeding 22.5% with reduced hysteresis in current–voltage scanning. Scale-up to 10×10 cm² modules by slot-die coating requires precise inline viscometry (10–15 cP) and a drying gradient from 50 °C to 120 °C across 4 m oven length. Compliance with ISO 14644-1 Class 5 cleanroom protocols prevents particulate defects that cause shunting. The ultimate products are hermetically sealed glass-glass minimodules for BIPV and off-grid IoT power supply.

Can a Halogen-Free Pyrrole Derivative Replace TEMPO as a Radical Mediator in Controlled Polymerization?

Nitroxide-mediated polymerization (NMP) traditionally relies on 2,2,6,6-tetramethylpiperidin-1-oxyl (TEMPO) as the stable radical mediator, yet the search for alternatives with faster dissociation rate coefficients (k_d) at lower temperatures has led to investigations of pyrrole-derived nitroxides synthesized from 3,5-dimethylpyrrole-2-carboxylic acid ethyl ester. After oxidation of the pyrrole with m-chloroperoxybenzoic acid (1.1 equiv, 0 °C to room temperature) and subsequent trapping with tert-butylphenylnitrone, the corresponding nitroxyl radical exhibits a k_d of approximately 0.015 s⁻¹ at 120 °C in styrene bulk polymerization, compared to 0.008 s⁻¹ for TEMPO under identical conditions as measured by electron spin resonance (ESR) in accordance with ASTM E386-15. The initiator system, formulated as a 1.5 mol% mixture of the nitroxide and benzoyl peroxide (BPO, 1.0 mol%), is dissolved in monomer and degassed via three freeze-pump-thaw cycles. Polymerization proceeds at 120 °C under argon in a Parr reactor with torque monitoring; the number-average molecular weight (M_n) tracks linearly with conversion up to 85%, maintaining a dispersity (Ð) of 1.18–1.25 as determined by size-exclusion chromatography in THF against polystyrene standards (ISO 16014-2:2019). Downstream, the polymer is precipitated into a tenfold excess of methanol, dried at 40 °C in vacuo, and pelletized for engineering thermoplastic evaluation. Industrial adoption, however, faces bottlenecks: residual nitroxide chromophore imparts a pale yellow tint to the final polymer, requiring post-treatment with sodium dithionite for decolorization, and the ethyl ester moiety of the precursor must be removed via hydrolysis to avoid volatile organic emission during melt processing at 240 °C. The end products are functionalized styrenic block copolymers used as compatibilizers in automotive polycarbonate/ABS blends, tested for impact strength per ISO 179-1/1eU.